179 related articles for article (PubMed ID: 33338697)
1. Effect of age, comorbidity and remission status on outcome of COVID-19 in patients with hematological malignancies.
Borah P; Mirgh S; Sharma SK; Bansal S; Dixit A; Dolai TK; Lunkad S; Gupta N; Singh G; Jain A; Bansal D; Choudhary D; Khandelwal V; Doval D; Kumar M; Bhargava R; Chakrabarti A; Kalashetty M; Rauthan A; Kazi B; Mandal PK; Jeyaraman P; Naithani R;
Blood Cells Mol Dis; 2021 Mar; 87():102525. PubMed ID: 33338697
[TBL] [Abstract][Full Text] [Related]
2. Convalescent plasma therapy for severe Covid-19 in patients with hematological malignancies.
Jeyaraman P; Agrawal N; Bhargava R; Bansal D; Ahmed R; Bhurani D; Bansal S; Rastogi N; Borah P; Naithani R;
Transfus Apher Sci; 2021 Jun; 60(3):103075. PubMed ID: 33574010
[TBL] [Abstract][Full Text] [Related]
3. A 5-day cytoreductive chemotherapy followed by haplo-identical hsct (FA5-BUCY) as a tumor-ablative regimen improved the survival of patients with advanced hematological malignancies.
Yang T; Lin Q; Ren J; Chen P; Yuan X; Luo X; Liu T; Zheng J; Zheng Z; Zheng X; Chen X; Zhang L; Zheng H; Chen Z; Hua X; Le S; Li J; Chen Z; Hu J
Oncotarget; 2016 Nov; 7(48):78773-78786. PubMed ID: 27705929
[TBL] [Abstract][Full Text] [Related]
4. Clinical profile and outcome of COVID-19 in haematological malignancies: experience from tertiary care centre in India.
Gupta A; Desai N; Sanjeev ; Chauhan P; Nityanand S; Hashim Z; Gupta M
Ann Hematol; 2022 Jan; 101(1):69-79. PubMed ID: 34559278
[TBL] [Abstract][Full Text] [Related]
5. The outcome of COVID-19 in patients with hematological malignancy.
Yigenoglu TN; Ata N; Altuntas F; Bascı S; Dal MS; Korkmaz S; Namdaroglu S; Basturk A; Hacıbekiroglu T; Dogu MH; Berber İ; Dal K; Erkurt MA; Turgut B; Ulgu MM; Celik O; Imrat E; Birinci S
J Med Virol; 2021 Feb; 93(2):1099-1104. PubMed ID: 32776581
[TBL] [Abstract][Full Text] [Related]
6. COVID-19 infection in adult patients with hematological malignancies: a European Hematology Association Survey (EPICOVIDEHA).
Pagano L; Salmanton-García J; Marchesi F; Busca A; Corradini P; Hoenigl M; Klimko N; Koehler P; Pagliuca A; Passamonti F; Verga L; Víšek B; Ilhan O; Nadali G; Weinbergerová B; Córdoba-Mascuñano R; Marchetti M; Collins GP; Farina F; Cattaneo C; Cabirta A; Gomes-Silva M; Itri F; van Doesum J; Ledoux MP; Čerňan M; Jakšić O; Duarte RF; Magliano G; Omrani AS; Fracchiolla NS; Kulasekararaj A; Valković T; Poulsen CB; Machado M; Glenthøj A; Stoma I; Ráčil Z; Piukovics K; Navrátil M; Emarah Z; Sili U; Maertens J; Blennow O; Bergantim R; García-Vidal C; Prezioso L; Guidetti A; Del Principe MI; Popova M; de Jonge N; Ormazabal-Vélez I; Fernández N; Falces-Romero I; Cuccaro A; Meers S; Buquicchio C; Antić D; Al-Khabori M; García-Sanz R; Biernat MM; Tisi MC; Sal E; Rahimli L; Čolović N; Schönlein M; Calbacho M; Tascini C; Miranda-Castillo C; Khanna N; Méndez GA; Petzer V; Novák J; Besson C; Duléry R; Lamure S; Nucci M; Zambrotta G; Žák P; Seval GC; Bonuomo V; Mayer J; López-García A; Sacchi MV; Booth S; Ciceri F; Oberti M; Salvini M; Izuzquiza M; Nunes-Rodrigues R; Ammatuna E; Obr A; Herbrecht R; Núñez-Martín-Buitrago L; Mancini V; Shwaylia H; Sciumè M; Essame J; Nygaard M; Batinić J; Gonzaga Y; Regalado-Artamendi I; Karlsson LK; Shapetska M; Hanakova M; El-Ashwah S; Borbényi Z; Çolak GM; Nordlander A; Dragonetti G; Maraglino AME; Rinaldi A; De Ramón-Sánchez C; Cornely OA;
J Hematol Oncol; 2021 Oct; 14(1):168. PubMed ID: 34649563
[TBL] [Abstract][Full Text] [Related]
7. COVID-19 in cancer patients on active systemic therapy - Outcomes from LMIC scenario with an emphasis on need for active treatment.
Ramaswamy A; Nayak L; Roy Moulik N; Sengar M; Chinnaswamy G; Jobanputra K; Shah MJ; Kapoor A; Joshi A; Kumar A; Gokarn A; Bonda A; Cheriyalinkal Parambil B; Prasad M; Bagal B; Dhamne C; Narula G; Jain H; Ghosh J; Thorat J; Bajpai J; Menon N; Khattry N; Bhargava P; Punatar S; Gulia S; Banavali S; Gupta S; Srinivas S; Rath S; Vora T; Noronha V; Patil VM; Ostwal V; Prabhash K
Cancer Med; 2020 Dec; 9(23):8747-8753. PubMed ID: 33128509
[TBL] [Abstract][Full Text] [Related]
8. Risk factors and outcomes of COVID-19 in adult patients with hematological malignancies: A single-center study showing lower than expected rates of hospitalization and mortality.
Aumann S; Tsubary U; Nachmias B; Ben Yehuda D; Lavie D; Goldschmidt N; Vainstein V; Libster D; Saban R; Shaulov A; Israel S; Avni B; Grisariu S; Bdolah-Amram T; Gatt M; Zimran E
Eur J Haematol; 2023 Jul; 111(1):135-145. PubMed ID: 37096337
[TBL] [Abstract][Full Text] [Related]
9. COVID-19 in patients with hematological malignancies: A retrospective case series.
Infante MS; González-Gascón Y Marín I; Muñoz-Novas C; Churruca J; Foncillas MÁ; Landete E; Marín K; Ryan P; Hernández-Rivas JÁ
Int J Lab Hematol; 2020 Dec; 42(6):e256-e259. PubMed ID: 32749757
[No Abstract] [Full Text] [Related]
10. Clinical characteristics, therapeutic management, and prognostic factors of adult COVID-19 inpatients with hematological malignancies.
Wu Y; Chen W; Li W; Zhao M; Wei Q; Zhang X; Mei H; Wang Y; Hu Y
Leuk Lymphoma; 2020 Dec; 61(14):3440-3450. PubMed ID: 32840399
[TBL] [Abstract][Full Text] [Related]
11. Donor Lymphocyte Infusion for Relapsed Hematological Malignancies after Unrelated Allogeneic Bone Marrow Transplantation Facilitated by the Japan Marrow Donor Program.
Miyamoto T; Fukuda T; Nakashima M; Henzan T; Kusakabe S; Kobayashi N; Sugita J; Mori T; Kurokawa M; Mori SI
Biol Blood Marrow Transplant; 2017 Jun; 23(6):938-944. PubMed ID: 28219836
[TBL] [Abstract][Full Text] [Related]
12. Clinical characteristics and outcomes of patients with haematologic malignancies and COVID-19 suggest that prolonged SARS-CoV-2 carriage is an important issue.
Arcani R; Colle J; Cauchois R; Koubi M; Jarrot PA; Jean R; Boyer A; Lachamp J; Tichadou A; Couderc AL; Farnault L; Costello R; Venton G; Kaplanski G
Ann Hematol; 2021 Nov; 100(11):2799-2803. PubMed ID: 34518918
[TBL] [Abstract][Full Text] [Related]
13. "Outcomes of COVID-19 infection in patients with hematological malignancies- A multicenter analysis from Pakistan".
Zaki A; Soomar SM; Khan DH; Shaharyar Sheikh H; Iftikhar R; Mir A; Aziz Z; Bano K; Naseer H; Chaudhry QU; Bokhari SWI; Shabbir-Moosajee M
PLoS One; 2022; 17(4):e0267139. PubMed ID: 35446898
[TBL] [Abstract][Full Text] [Related]
14. Risk Factors Associated With In-Hospital Mortality in a US National Sample of Patients With COVID-19.
Rosenthal N; Cao Z; Gundrum J; Sianis J; Safo S
JAMA Netw Open; 2020 Dec; 3(12):e2029058. PubMed ID: 33301018
[TBL] [Abstract][Full Text] [Related]
15. Covid-19 in patients with hematological and solid cancers at a Comprehensive Cancer Center in Germany.
Shoumariyeh K; Biavasco F; Ihorst G; Rieg S; Nieters A; Kern WV; Miething C; Duyster J; Engelhardt M; Bertz H
Cancer Med; 2020 Nov; 9(22):8412-8422. PubMed ID: 32931637
[TBL] [Abstract][Full Text] [Related]
16. The direct and indirect effects of COVID-19 pandemic in a real-life hematological setting.
Condom M; Mussetti A; Maluquer C; Parody R; González-Barca E; Arnan M; Albasanz-Puig A; Pomares H; Salas MQ; Carro I; Peña M; Clapes V; Baca Cano C; Oliveira Ramos AC; Sanz-Linares G; Moreno-González G; Mercadal S; Boqué C; Gudiol C; Domingo-Domènech E; Sureda A
Cancer Rep (Hoboken); 2021 Aug; 4(4):e1358. PubMed ID: 33656801
[TBL] [Abstract][Full Text] [Related]
17. [Features of COVID-19 infection among patients with hematological malignancies].
Fissore G; Skog S; Lastra J; Chandía M
Rev Med Chil; 2022 May; 150(5):625-633. PubMed ID: 37906763
[TBL] [Abstract][Full Text] [Related]
18. Factors Associated with a Positive Severe Acute Respiratory Syndrome Coronavirus 2 Testing in Suspected Cases Presenting with Pneumonia: A Retrospective Cohort Study in a Single Medical Center.
Li Y; Shang Y; Yang Y; Wang M; Yu D; Su D; Liu L; Wang Q; Zhang X; Ren J; Chen H
Respiration; 2020; 99(9):739-747. PubMed ID: 33207356
[TBL] [Abstract][Full Text] [Related]
19. COVID-19 in cancer patients: clinical characteristics and outcome-an analysis of the LEOSS registry.
Rüthrich MM; Giessen-Jung C; Borgmann S; Classen AY; Dolff S; Grüner B; Hanses F; Isberner N; Köhler P; Lanznaster J; Merle U; Nadalin S; Piepel C; Schneider J; Schons M; Strauss R; Tometten L; Vehreschild JJ; von Lilienfeld-Toal M; Beutel G; Wille K;
Ann Hematol; 2021 Feb; 100(2):383-393. PubMed ID: 33159569
[TBL] [Abstract][Full Text] [Related]
20. COVID-19 in 96 Patients With Hematologic Disease: The First Single-center Experience From the Czech Republic.
Čerňan M; Szotkowski T; Obr A; Látal V; Hluší A; Krhovská P; Klementová O; Kolář M; Sauer P; Faber E; Fürst T; Papajík T
Clin Lymphoma Myeloma Leuk; 2021 Sep; 21(9):606-612. PubMed ID: 34083176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
